Compugen Ltd. to Review Second Quarter 2008 Results on Tuesday, July 29, 2008
22 July 2008 - 9:00PM
Business Wire
Compugen Ltd. (NASDAQ:CGEN) today announced that the Company plans
to host a live conference call and webcast at 10:00 AM EDT on
Tuesday, July 29, 2008 to review second quarter 2008 results. The
quarterly results will be released prior to the conference call.
During the call, management will also provide additional
information regarding Compugen�s recently announced drug candidate
for breast cancer therapy. To access the conference call, please
dial 1-866-345-5855 from the US or +972-3-918-0688 internationally.
The call will also be available via live webcast through Compugen�s
Website, located at www.cgen.com. A replay of the conference call
will be available approximately two hours after the completion of
the live conference call. To access the replay, please dial
1-888-326-9310 from the US or +972-3�925-5944. The replay will be
available until 12 noon EDT on August 1, 2008. About Compugen
Compugen�s mission is to be the world leader in the discovery and
licensing of product candidates to the drug and diagnostic
industries under milestone and revenue sharing agreements. The
Company�s increasing inventory of powerful and proprietary
discovery platforms is enabling the predictive discovery � field
after field � of numerous therapeutic and diagnostic product
candidates. These discovery platforms are based on the Company�s
decade-long focus on the predictive understanding of important
biological phenomena at the molecular level. Compugen�s current
collaborations include Biosite, Medarex, Inc., Merck & Co.,
Inc., Ortho-Clinical Diagnostics (a Johnson & Johnson company),
Roche, Siemens Healthcare Diagnostics, Inc., and Teva
Pharmaceutical Industries. In 2002, Compugen established an
affiliate, Evogene Ltd. (TASE: EVGN.TA), to utilize the Company�s
in-silico predictive discovery capabilities in the agricultural
biotechnology field. For additional information, please visit
Compugen's corporate Website at www.cgen.com and Evogene�s
corporate Website at www.evogene.com.
Compugen (NASDAQ:CGEN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Compugen (NASDAQ:CGEN)
Historical Stock Chart
From Jul 2023 to Jul 2024